Background: The existence of bipolar disorder type I (BD-I) during adolescence is now clearly established whereas there are still some controversies on BD-II and BD-NOS diagnosis, mainly in Europe (O'Dowd in Br Med J 29, 2006). Little is known on the phenomenology and potential short-term prognosis factors of bipolar episodes in this age population. In particular, very few studies examine this issue on inpatients in the European context of free access to care. Objective: To describe the phenomenology of acute manic and mixed episodes in hospitalized adolescents and to analyse potential predictive factors associated with clinical improvement at discharge and length of hospitalization. Methods: A total of 80 subjects, aged 12–20 years, consec...
Tran et al Objective: We present the case of an 11 year-old girl admitted to the Centre hospitalier ...
Aim. The main objectives of this a naturalistic, prospective follow-up study were to describe the cl...
Objective: In the absence of recommendations from drug regulatory agencies for most medications to t...
j Abstract Background The existence of bipolar disorder type I (BD-I) during adolescence is now clea...
Background: The existence of bipolar disorder type I (BD-I) during adolescence is now clearly establ...
Background. Reported rates of bipolar syndromes are highly variable between studies because of age d...
Objectives: Bipolar disorder (BD) is a debilitating illness that often starts at an early age. Preve...
There has recently been an intense debate about the increased rate of bipolar disorders (BPD) in chi...
rospective studies of bipolar disorders (BDs) in children and adolescents are few and the findings c...
Introduction: The therapeutic outcome of children’s and adolescents’ bipolar disorder was affected b...
Objectives: Bipolar disorder (BD) is a debilitating illness that often starts at an early age. Preve...
BACKGROUND:Traditional assessment and treatment of bipolar disorder (BD) often overlooks an importan...
ObjectiveThe Course and Outcome of Bipolar Youth study found that children and adolescents with bipo...
Objective: Phenomenological and treatment differences between children and adolescents with bipolar ...
Managing bipolar youths in a psychiatric inpatient emergency service. Masi G, Mucci M, Pias P...
Tran et al Objective: We present the case of an 11 year-old girl admitted to the Centre hospitalier ...
Aim. The main objectives of this a naturalistic, prospective follow-up study were to describe the cl...
Objective: In the absence of recommendations from drug regulatory agencies for most medications to t...
j Abstract Background The existence of bipolar disorder type I (BD-I) during adolescence is now clea...
Background: The existence of bipolar disorder type I (BD-I) during adolescence is now clearly establ...
Background. Reported rates of bipolar syndromes are highly variable between studies because of age d...
Objectives: Bipolar disorder (BD) is a debilitating illness that often starts at an early age. Preve...
There has recently been an intense debate about the increased rate of bipolar disorders (BPD) in chi...
rospective studies of bipolar disorders (BDs) in children and adolescents are few and the findings c...
Introduction: The therapeutic outcome of children’s and adolescents’ bipolar disorder was affected b...
Objectives: Bipolar disorder (BD) is a debilitating illness that often starts at an early age. Preve...
BACKGROUND:Traditional assessment and treatment of bipolar disorder (BD) often overlooks an importan...
ObjectiveThe Course and Outcome of Bipolar Youth study found that children and adolescents with bipo...
Objective: Phenomenological and treatment differences between children and adolescents with bipolar ...
Managing bipolar youths in a psychiatric inpatient emergency service. Masi G, Mucci M, Pias P...
Tran et al Objective: We present the case of an 11 year-old girl admitted to the Centre hospitalier ...
Aim. The main objectives of this a naturalistic, prospective follow-up study were to describe the cl...
Objective: In the absence of recommendations from drug regulatory agencies for most medications to t...